EX-99.1 2 ex-99d1.htm EX-99.1 veco_Ex99_1

EXHIBIT 99.1

 

Picture 3

 

VEECO REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS

 

Third Quarter 2019 Highlights:

 

·

Revenues of $109.0 million, compared with $126.8 million in the same period last year

·

GAAP net loss of $11.8 million, or $0.25 loss per diluted share

·

Non-GAAP net income of $2.6 million, or $0.05 per diluted share

 

Plainview, N.Y., November 4, 2019 -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2019. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release. 

 

 

  U.S. Dollars in millions, except per share data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Results

    

Q3 ’19

    

Q3 ’18

 

Revenue

 

$

109.0

 

$

126.8

 

Net income (loss)

 

$

(11.8)

 

$

(9.0)

 

Diluted earnings (loss) per share

 

$

(0.25)

 

$

(0.19)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Results

    

Q3 ’19

    

Q3 ’18

 

Net income (loss)

 

$

2.6

 

$

5.3

 

Operating income (loss)

 

$

4.0

 

$

8.0

 

Diluted earnings (loss) per share

 

$

0.05

 

$

0.11

 

 

 

“Veeco executed well in Q3 with revenue and EPS above the midpoint of our guided range.  Our gross margin exceeded our guidance and the company returned to profitability on a non-GAAP basis,” commented William J. Miller, Ph.D., Chief Executive Officer. “We continue to experience demand for our EUV mask blank products and have shipped our second production system. This shipment, combined with revenue from multiple LSA systems, drove strong Front End Semiconductor sales. Additionally, shipments to our data storage customers remained solid as they continued to invest in technology and capacity.”

 

 

 

 

 

 

 

 

 

 

1

Guidance and Outlook

 

The following guidance is provided for Veeco’s fourth quarter 2019:

 

·

Revenue is expected in the range of $100 million to $120 million

·

GAAP loss per share is expected in the range of ($0.32) to ($0.10)  

·

Non-GAAP earnings (loss) per share are expected in the range of $(0.03) to $0.18 

 

Please refer to the tables at the end of this press release for further details.

 

Conference Call Information

 

A conference call reviewing these results has been scheduled for today, November 4, 2019 starting at 5:00pm ET. To join the call, dial 1-888-394-8218 (toll free) or 1-646-828-8193 and use passcode 9227350. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

 

About Veeco 

 

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

 

Forward-looking Statements

 

To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Management's Discussion and Analysis sections of Veeco's Annual Report on Form 10-K for the year ended December 31, 2018 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

 

 

 

-financial tables attached-

 

Veeco Contacts:

 

Investors: Media:

Anthony Bencivenga (516) 252-1438Kevin Long (516)  714-3978

abencivenga@veeco.comklong@veeco.com

2

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)
(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

    

2019

    

2018

    

2019

    

2018

 

Net sales

 

$

108,954

 

$

126,757

 

$

306,147

 

$

443,110

 

Cost of sales

 

 

66,731

 

 

80,372

 

 

192,924

 

 

284,651

 

Gross profit

 

 

42,223

 

 

46,385

 

 

113,223

 

 

158,459

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

22,639

 

 

23,544

 

 

68,901

 

 

72,793

 

Selling, general, and administrative

 

 

20,962

 

 

20,186

 

 

60,620

 

 

70,842

 

Amortization of intangible assets

 

 

4,312

 

 

4,183

 

 

12,773

 

 

28,102

 

Restructuring

 

 

1,828

 

 

2,057

 

 

3,874

 

 

7,669

 

Acquisition costs

 

 

 —

 

 

249

 

 

 —

 

 

2,906

 

Asset impairment

 

 

 —

 

 

 —

 

 

 —

 

 

252,343

 

Other, net

 

 

(153)

 

 

39

 

 

(232)

 

 

325

 

Total operating expenses, net

 

 

49,588

 

 

50,258

 

 

145,936

 

 

434,980

 

Operating income (loss)

 

 

(7,365)

 

 

(3,873)

 

 

(32,713)

 

 

(276,521)

 

Interest expense, net

 

 

(4,330)

 

 

(4,779)

 

 

(12,742)

 

 

(13,847)

 

Income (loss) before income taxes

 

 

(11,695)

 

 

(8,652)

 

 

(45,455)

 

 

(290,368)

 

Income tax expense (benefit)

 

 

72

 

 

301

 

 

407

 

 

(27,954)

 

Net income (loss)

 

$

(11,767)

 

$

(8,953)

 

$

(45,862)

 

$

(262,414)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.25)

 

$

(0.19)

 

$

(0.97)

 

$

(5.55)

 

Diluted

 

$

(0.25)

 

$

(0.19)

 

$

(0.97)

 

$

(5.55)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

47,489

 

 

46,982

 

 

47,361

 

 

47,283

 

Diluted

 

 

47,489

 

 

46,982

 

 

47,361

 

 

47,283

 

 

3

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

 

 

 

 

 

 

September 30,

 

December 31,

 

    

2019

    

2018

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

135,259

 

$

212,273

Restricted cash

 

 

687

 

 

809

Short-term investments

 

 

95,672

 

 

48,189

Accounts receivable, net

 

 

72,731

 

 

66,808

Contract assets

 

 

20,782

 

 

10,397

Inventories

 

 

135,190

 

 

156,311

Deferred cost of sales

 

 

2,198

 

 

3,072

Prepaid expenses and other current assets

 

 

23,762

 

 

22,221

Total current assets

 

 

486,281

 

 

520,080

Property, plant and equipment, net

 

 

77,801

 

 

80,284

Operating lease right-of-use assets

 

 

10,472

 

 

 —

Intangible assets, net

 

 

72,376

 

 

85,149

Goodwill

 

 

184,302

 

 

184,302

Deferred income taxes

 

 

1,872

 

 

1,869

Other assets

 

 

29,172

 

 

29,132

Total assets

 

$

862,276

 

$

900,816

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

34,702

 

$

39,611

Accrued expenses and other current liabilities

 

 

40,641

 

 

46,450

Customer deposits and deferred revenue

 

 

66,031

 

 

72,736

Income taxes payable

 

 

663

 

 

1,256

Total current liabilities

 

 

142,037

 

 

160,053

Deferred income taxes

 

 

5,713

 

 

5,690

Long-term debt

 

 

296,810

 

 

287,392

Operating lease long-term liabilities

 

 

6,066

 

 

 —

Other liabilities

 

 

9,180

 

 

9,906

Total liabilities

 

 

459,806

 

 

463,041

 

 

 

 

 

 

 

Total stockholders’ equity

 

 

402,470

 

 

437,775

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

862,276

 

$

900,816

4

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

 

 

 

 

Share-Based

 

 

 

 

 

 

 

 

Three months ended September 30, 2019

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

 

Net sales

 

$

108,954

 

 

 

 

 

 

 

$

108,954

 

Gross profit

 

 

42,223

 

383

 

 

 

1,316

 

 

43,922

 

Gross margin

 

 

38.8

%

 

 

 

 

 

 

 

40.3

%

Operating expenses

 

 

49,588

 

(3,400)

 

(4,312)

 

(1,920)

 

 

39,956

 

Operating income (loss)

 

 

(7,365)

 

3,783

 

4,312

 

3,236

^

 

3,966

 

Net income (loss)

 

 

(11,767)

 

3,783

 

4,312

 

6,302

^

 

2,630

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.25)

 

 

 

 

 

 

 

$

0.06

 

Diluted

 

 

(0.25)

 

 

 

 

 

 

 

 

0.05

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

47,489

 

 

 

 

 

 

 

 

47,495

 

Diluted

 

 

47,489

 

 

 

 

 

 

 

 

47,898

 


^- See table below for additional details.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

 

 

 

Three months ended September 30, 2019

    

 

Restructuring

 

1,828

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

1,270

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

138

Subtotal

 

3,236

Non-cash interest expense

 

3,199

Non-GAAP tax adjustment *

 

(133)

Total Other

 

6,302


*- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

5

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

 

 

 

 

Share-based

 

 

 

 

 

 

 

Three months ended September 30, 2018

    

 

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

 

Net sales

 

$

126,757

 

 

 

 

 

 

 

$

126,757

 

Gross profit

 

 

46,385

 

513

 

 

 

1,489

 

 

48,387

 

Gross margin

 

 

36.6

%  

 

 

 

 

 

 

 

38.2

%

Operating expenses

 

 

50,258

 

(2,766)

 

(4,183)

 

(2,892)

 

 

40,417

 

Operating income (loss)

 

 

(3,873)

 

3,279

 

4,183

 

4,381

^

 

7,970

 

Net income (loss)

 

 

(8,953)

 

3,279

 

4,183

 

6,813

^

 

5,322

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.19)

 

 

 

 

 

 

 

$

0.11

 

Diluted

 

 

(0.19)

 

 

 

 

 

 

 

 

0.11

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

46,982

 

 

 

 

 

 

 

 

46,984

 

Diluted

 

 

46,982

 

 

 

 

 

 

 

 

47,000

 


^- See table below for additional details.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

 

 

 

Three months ended September 30, 2018

 

 

Restructuring

    

1,890

Acquisition related

 

249

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

1,411

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

236

Accelerated depreciation

 

595

Subtotal

 

4,381

Non-cash interest expense

 

2,968

Non-GAAP tax adjustment *

 

(536)

Total Other

 

6,813


*- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

6

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)

(in thousands)
(unaudited)

 

 

 

 

 

 

 

 

    

Three months ended

    

Three months ended

 

 

September 30, 2019

 

September 30, 2018

GAAP Net income (loss)

 

$

(11,767)

 

$

(8,953)

Share-based compensation

 

 

3,783

 

 

3,279

Amortization

 

 

4,312

 

 

4,183

Restructuring

 

 

1,828

 

 

1,890

Acquisition related

 

 

 —

 

 

249

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

 

1,270

 

 

1,411

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

 

138

 

 

236

Accelerated depreciation

 

 

 —

 

 

595

Interest (income) expense, net

 

 

4,330

 

 

4,779

Income tax expense (benefit)

 

 

72

 

 

301

Non-GAAP Operating income (loss)

 

$

3,966

 

$

7,970

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

7

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in millions, except per share amounts)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

 

 

 

 

Guidance for the three months ending

 

 

 

 

 

 

 

 

 

Share-based

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

GAAP

 

Compensation

 

Amortization

 

   Other    

 

Non-GAAP

 

Net sales

    

$

100

    

-

    

$

120

    

 

    

 

    

 

    

$

100

    

-

    

$

120

 

Gross profit

 

 

38

 

-

 

 

48

 

 1

 

 —

 

 —

 

 

39

 

-

 

 

49

 

Gross margin

 

 

39%

 

-

 

 

41%

 

 

 

 

 

 

 

 

39%

 

-

 

 

41%

 

Operating expenses

 

 

 

~$48

 

 

 

 3

 

 4

 

 2

 

 

 

~$39

 

 

 

Operating income (loss)

 

 

(10)

 

-

 

 

 —

 

 4

 

 4

 

 2

 

 

 —

 

-

 

 

10

 

Net income (loss)

 

$

(15)

 

-

 

$

(5)

 

 4

 

 4

 

 5

 

$

(2)

 

-

 

$

 8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per diluted common share

 

$

(0.32)

 

-

 

$

(0.10)

 

  

 

  

 

  

 

$

(0.03)

 

-

 

$

0.18

 

Weighted average number of shares

 

 

48

 

 

 

 

48

 

 

 

 

 

 

 

 

48

 

 

 

 

48

 

 

 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)

(in millions)
(unaudited)

 

 

 

 

 

 

 

 

 

Guidance for the three months ending December 31, 2019

    

 

 

    

 

    

 

 

GAAP Net income (loss)

 

$

(15)

 

-

 

$

(5)

Share-based compensation

 

 

 4

 

-

 

 

 4

Amortization

 

 

 4

 

-

 

 

 4

Restructuring

 

 

 2

 

-

 

 

 2

Interest expense, net

 

 

 4

 

-

 

 

 4

Other

 

 

 1

 

-

 

 

 1

Non-GAAP Operating income (loss)

 

$

 —

 

-

 

$

10

 

Note: Amounts may not calculate precisely due to rounding.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

8